Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dufek

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Plos One|June 11, 2014
Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesisDuane Delimont, Brianna M Dufek, Daniel T Meehan, et al.
Vnitrni Lekarstvi|January 15, 2010
[Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease]Z Adam, K Balsíková, L Pour, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis and Related Disorders|August 11, 2019
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuSD Horakova, P Rockova, J Jircikova, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Plos One|June 11, 2014
Laminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesisDuane Delimont, Brianna M Dufek, Daniel T Meehan, et al.
Vnitrni Lekarstvi|January 15, 2010
[Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease]Z Adam, K Balsíková, L Pour, et al.
Journal of Neurology|October 22, 2010
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosisD G MacManus, D H Miller, L Kappos, et al.
Multiple Sclerosis and Related Disorders|August 11, 2019
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuSD Horakova, P Rockova, J Jircikova, et al.
Pageof 3